<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">James, Stefan</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">4-Year Follow-up Shows No Increased Mortality with Drug-Eluting Stents Compared to Bare Metal Stents in over 60,000 Patients</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-10</style></pages><abstract><style  face="normal" font="default" size="100%">According to the updated results from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR], which now contains up to 4 years of follow-up data for more than 60,000 patients, mortality rates in patients with drug-eluting stents are no higher than in those with bare metal stents.</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">7</style></volume></record></records></xml>